Status:
UNKNOWN
Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer
Lead Sponsor:
Institute of Oncology Ljubljana
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
The goal of this study is gathering informations about patients' quality of life after combined modality treatment of rectal cancer to evaluate how combined modality treatment for rectal cancer affect...
Detailed Description
Over the last two decades, rectal cancer research has lead to better understanding of disease behaviour, resulting in more efficient treatments and higher prevalence of cancer survivors.Due to aggress...
Eligibility Criteria
Inclusion
- histologically verified adenocarcinoma of the rectum,
- clinical stage II or III (IUCC TNM classification 2002);
- no prior radiotherapy and/or chemotherapy;
- World Health Organisation (WHO) performance status \< 2;
- age at diagnosis of 18 or older;
- and adequate bone marrow, liver, renal and cardiac function (no history of ischemic heart disease)
- mentally fit to complete questionnaires
Exclusion
- a history of prior malignancy other than non-melanoma skin cancer or in situ carcinoma of the cervix rendered the patient ineligible.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT01152164
Start Date
January 1 2008
End Date
September 1 2012
Last Update
March 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Oncology
Ljubljana, Slovenia, Slovenia, 1000